Literature DB >> 22517125

Risk factors for mesh complications after trocar guided transvaginal mesh kit repair of anterior vaginal wall prolapse.

Caroline Elmér1, Christian Falconer, Anders Hallin, Gregor Larsson, Marion Ek, Daniel Altman.   

Abstract

AIMS: To identify risk factors for mesh exposures after anterior pelvic organ prolapse repair using a standardized trocar guided polypropylene mesh kit.
METHODS: A secondary risk analysis combining patients from two prospective multicenter studies. Main outcome was clinical host-vs-implant reactions one year after surgery using a macroscopic inflammatory scale.
RESULTS: 353 patients were included in the study. Mean age at surgery was 65.3 (± 9.6 SD) years and surgery was performed as a primary procedure in 224/353 (63.5%) patients. Mesh exposures, of which the majority were mild-moderate, occurred in a total of 30/349 patients (8.6%). Multivariate logistic regression showed increased odds for mesh exposures for women who smoked before surgery (OR 3.48, 95% CI 1.18-10.28), who had given birth to more than two children (OR 2.64, 95% CI 1.07-6.51) and those with somatic inflammatory disease (OR 5.11, 95% CI 1.17-22.23). Age, body mass index, and menopausal status showed no significant association with clinical mesh exposures.
CONCLUSIONS: Smoking, multiple childbirth, and somatic inflammatory disease are possible risk factors for mesh exposure after trocar guided mesh kit surgery for anterior pelvic organ prolapse. Preoperative smoking cessation may decrease the risk for exposures.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517125     DOI: 10.1002/nau.22231

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  5 in total

1.  Seeking new surgical predictors of mesh exposure after transvaginal mesh repair.

Authors:  Pei-Ying Wu; Chih-Hung Chang; Meng-Ru Shen; Cheng-Yang Chou; Yi-Ching Yang; Yu-Fang Huang
Journal:  Int Urogynecol J       Date:  2016-03-18       Impact factor: 2.894

2.  Lower exposure rates of partially absorbable mesh compared to nonabsorbable mesh for cystocele treatment: 3-year follow-up of a prospective randomized trial.

Authors:  J Farthmann; D Watermann; A Niesel; C Fünfgeld; A Kraus; F Lenz; H J Augenstein; E Graf; B Gabriel
Journal:  Int Urogynecol J       Date:  2012-08-29       Impact factor: 2.894

Review 3.  Host-biomaterial interactions in mesh complications after pelvic floor reconstructive surgery.

Authors:  Roxanna E Abhari; Matthew L Izett-Kay; Hayley L Morris; Rufus Cartwright; Sarah J B Snelling
Journal:  Nat Rev Urol       Date:  2021-09-20       Impact factor: 14.432

4.  Changes in prolapse surgery trends relative to FDA notifications regarding vaginal mesh.

Authors:  Laura C Skoczylas; Lindsay C Turner; Li Wang; Daniel G Winger; Jonathan P Shepherd
Journal:  Int Urogynecol J       Date:  2013-10-01       Impact factor: 2.894

5.  Long-term outcomes of pelvic organ prolapse repair using a mesh-capturing device when comparing single- versus multicenter use.

Authors:  Christian Falconer; Daniel Altman; Georgios Poutakidis; Päivi Rahkola-Soisalo; Tomi Mikkola; Edward Morcos
Journal:  Arch Gynecol Obstet       Date:  2020-09-11       Impact factor: 2.344

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.